Canada markets closed

Stayble Therapeutics AB (publ) (STABL.ST)

Stockholm - Stockholm Real Time Price. Currency in SEK
Add to watchlist
0.2335-0.0160 (-6.41%)
At close: 05:24PM CEST
Currency in SEK

Valuation Measures4

Market Cap (intraday) 7.41M
Enterprise Value -13.89M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.32
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA 0.63

Trading Information

Stock Price History

Beta (5Y Monthly) -0.07
52-Week Change 3-84.59%
S&P500 52-Week Change 322.36%
52 Week High 36.4200
52 Week Low 30.1900
50-Day Moving Average 30.2552
200-Day Moving Average 31.7383

Share Statistics

Avg Vol (3 month) 3179.63k
Avg Vol (10 day) 3109.32k
Shares Outstanding 531.72M
Implied Shares Outstanding 631.72M
Float 829.41M
% Held by Insiders 133.42%
% Held by Institutions 118.56%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-73.44%
Return on Equity (ttm)-149.34%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-23.74M
Diluted EPS (ttm)-1.0100
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)14.08M
Total Cash Per Share (mrq)0.44
Total Debt (mrq)850k
Total Debt/Equity (mrq)5.15%
Current Ratio (mrq)3.69
Book Value Per Share (mrq)0.52

Cash Flow Statement

Operating Cash Flow (ttm)-23.54M
Levered Free Cash Flow (ttm)-15.02M